Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) – Use of metformin is associated with a decreased risk of pancreatic cancer in patients with diabetes, new research shows. By contrast, treatment with…
NEW YORK (Reuters Health) – Even when patients with type 1 diabetes have excellent hemoglobin A1C levels, continuous glucose monitoring will be beneficial, according to a report in…
NEW YORK (Reuters Health) – Prehypertensive men who are physically fit are likely to live longer as a result, according to a long-term follow-up study published in the…
Chad Deal, MD, Rheumatologist, Head, Center for Osteoporosis and Metabolic Bone Disease, Cleveland Clinic, discusses denosumab, a new treatment for osteoporosis now being used to treat patients who…
Daniel Mazanec, MD, FACP, FACR, Associate Director, Center for Spine Health Cleveland Clinic, discusses medical acupuncture and its physiology. Summary: Acupuncture needling with electrical stimulation produces release of…
Daniel Mazanec, MD, FACP, FACR, Associate Director, Center for Spine Health Cleveland Clinic, discusses medical acupuncture and its role in western medicine treating headache, musculoskeletal disorders including osteoarthritis.…
NEW YORK (Reuters Health) – In trials of antimuscarinic agents for overactive bladder, the placebo responses tend to be large, statistically significant, and heterogeneous, according to a meta-analysis…
NEW YORK (Reuters Health) – New research suggests that the time it takes for an ambulance to transport a cardiac arrest patient from the field to the hospital…
NEW YORK (Reuters Health) – Using 30% rather than 90% oxygen to resuscitate extremely low gestational age neonates results in less oxidative stress, inflammation, and chronic lung disease,…
NEW YORK (Reuters Health) – Some modulators of 5-hydroxytryptamine (5-HT) appear to be effective in relieving symptoms of irritable bowel syndrome (IBS), the results of a systematic review…
